Journal
EPIGENOMICS
Volume 6, Issue 4, Pages 415-426Publisher
FUTURE MEDICINE LTD
DOI: 10.2217/epi.14.34
Keywords
DNA methylation; epigenetic modifications; histone methylation; microRNA; prostate cancer
Categories
Funding
- La Ligue contre le Cancer - Comites de la region Auvergne
- Scientific and Technology Research Council of Turkey (TUBITAK) [2219]
- Protema Saglik Hizm
Ask authors/readers for more resources
Prostate cancer is the most common cancer in men and the second leading cause of cancer deaths in men in France. Apart from the genetic alterations in prostate cancer, epigenetics modifications are involved in the development and progression of this disease. Epigenetic events are the main cause in gene regulation and the three most epigenetic mechanisms studied include DNA methylation, histone modifications and microRNA expression. In this review, we summarized epigenetic mechanisms in prostate cancer. Epigenetic drugs that inhibit DNA methylation, histone methylation and histone acetylation might be able to reactivate silenced gene expression in prostate cancer. However, further understanding of interactions of these enzymes and their effects on transcription regulation in prostate cancer is needed and has become a priority in biomedical research. In this study, we summed up epigenetic changes with emphasis on pharmacologic epigenetic target agents.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available